A*STAR and NUS Researchers Score Breakthrough in Developing Unlimited Number of Pure Insulin-Producing Cells
Researchers have scored a breakthrough in developing an unlimited number of pure insulin-producing cells from mouse embryonic stem cells.

Neurons Derived from Embryonic Stem Cells Restore Muscle Function after Injury
Dalhousie Medical School researchers have discovered that embryonic stem cells may play a critical role in helping people with nerve damage and motor neuron diseases, such as amyotrophic lateral sclerosis, regain muscular strength.

Correlation Between Preimplantation Genetic Diagnosis for Chromosomal Aneuploidies and the Efficiency of Establishing Human Embryonic Stem Cell Lines
The researchers report on the efficiency of establishing hESC lines from blastocysts with proven meiotic or mitotic errors after sequential testing of both polar bodies and blastomere analysis on day 3.

Stem Cell Sciences Signs Service Agreement with Pfizer to Provide Access to Proprietary Technologies and Methods
Stem Cell Sciences plc has signed a Master Service Agreement of up to five years with Pfizer Limited to provide research services, cell lines, media and reagents to support Pfizer's R&D efforts in this important field.

Pfizer Opens £40 Million Stem Cell Research Lab in Cambridge
Drugs giant Pfizer has pledged to invest £40 million in a new stem cell research centre in Cambridge.

Cellular Dynamics International Merges Companies, Closes on $18 Million Financing
Cellular Dynamics International announced recently the merger of sister companies Stem Cell Products Inc. and iPS Cells Inc. with CDI.

Sigma-Aldrich Enters Into Research Collaboration Program with D-Finitive Cell Technologies, Inc., to Develop Research Tools for Regenerative Medicine
Sigma-Aldrich announced recently it has entered into a research collaboration program with D-Finitive Cell Technologies, Inc. to support the development and commercial offering of 14 products over a two-year span, with a planned launch of many of these products in 2009.

Obama Should Tap Personalized Medicine Tools, Leavitt Says
President-elect Barack Obama should explore tools of personalized medicine, such as genetic tests and online health records, to mend the U.S. health-care system, said Michael Leavitt, the outgoing health secretary.